Sporadic pregnancy loss and recurrent miscarriage.


Journal

Best practice & research. Clinical obstetrics & gynaecology
ISSN: 1532-1932
Titre abrégé: Best Pract Res Clin Obstet Gynaecol
Pays: Netherlands
ID NLM: 101121582

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 09 07 2020
revised: 16 08 2020
accepted: 01 09 2020
pubmed: 27 9 2020
medline: 25 11 2020
entrez: 26 9 2020
Statut: ppublish

Résumé

Progesterone is essential for the maintenance of pregnancy, and progesterone deficiency is associated with miscarriage. The subject of whether progesterone supplementation in early pregnancy can prevent miscarriage has been a long-standing research question and has been investigated and debated in the medical literature for over 70 years. During this time, several different progestogens have been synthesised and tested for the prevention of miscarriage. In this chapter, we describe the prior evidence alongside the latest research using micronized natural progesterone as well as synthetic progestogens, which were used to treat both recurrent and threatened miscarriage. The totality of evidence indicates that women with a past history of miscarriage who present with bleeding in early pregnancy may benefit from the use of vaginal micronized progesterone. The clinical implications of the findings are discussed.

Identifiants

pubmed: 32978069
pii: S1521-6934(20)30141-3
doi: 10.1016/j.bpobgyn.2020.09.002
pii:
doi:

Substances chimiques

Progestins 0
Progesterone 4G7DS2Q64Y

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

30-39

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of competing interest There are no conflicts of interest to report.

Auteurs

Adam J Devall (AJ)

Tommy's National Centre for Miscarriage Research, College of Medical and Dental Sciences, University of Birmingham, UK.

Arri Coomarasamy (A)

Tommy's National Centre for Miscarriage Research, College of Medical and Dental Sciences, University of Birmingham, UK. Electronic address: a.coomarasamy@bham.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH